Cancer screening with whole-body 18F-fluorodeoxyglucose positron-emission tomography

Lancet. 1997 Dec;350(9094):1819. doi: 10.1016/s0140-6736(97)24051-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / diagnostic imaging*
  • Tomography, Emission-Computed*

Substances

  • Fluorodeoxyglucose F18